Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency

Journal of Lipid Research

Volumn 49, Issue 1, 2008, Pages 24-32

  Valenta, David T ^a   Bulgrien, Joshua J ^a   Bonnet, David J ^a   Curtiss, Linda K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Bone marrow transplant; Inflammation; Low density lipoprotein receptor; Phospholipid transfer protein

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHOLIPID TRANSFER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SINUS; ARTICLE; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; HEART PROTECTION; ISCHEMIC HEART DISEASE; LIPID DIET; LIPOPROTEIN METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; BONE MARROW TRANSPLANTATION; CHOLESTEROL; HYPERCHOLESTEROLEMIA; MACROPHAGES; MICE; MICE, MUTANT STRAINS; PHOSPHOLIPID TRANSFER PROTEINS; RECEPTORS, LDL;

EID: 38049098116     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700228-JLR200     Document Type: Article

References (36)

1. Van Haperen, R., A. van Tol, T. van Gent, L. Scheek, P. Visser, A. van der Kamp, F. Grosveld, and R. de Crom. 2002. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J. Biol. Chem. 277: 48938-48943.
2. Schlitt, A., C. Bickel, P. Thumma, S. Blanckenberg, H. J. Rupperecht, J. Meyer, and X-C. Jiang. 2003. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 23: 1857-1862.
3. Ehnholm, S., K. W. van Dijk, B. van't Hof, A. van der Zee, V. M. Olkkonen, M. Jauhiainen, M. Hofker, L. Havekes, and C. Ehnholm. 1998. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J. Lipid Res. 39: 1248-1253.
4. Jaari, S., K. W. van Dijk, V. M. Olkkonen, A. van der Dee, J. Metso, L. Havekes, M. Juahiainen, and C. Ehnholm. 2001. Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): importance of PLTP in preb-HDL generation. Comp. Biochem. Physiol. 128: 781-792.
5. Föger, B., S. Santamarina-Fojo, R. D. Shamburek, C. L. Parrot, G. D. Talley, and H. B. Brewer, Jr. 1997. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoproteins (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J. Biol. Chem. 272: 27393-27400.
6. Yang, X. P., D. Yan, C. Qiao, R. J. Liu, J-G. Chen, J. Li, M. Schneider, L. Lagrost, X. Xiao, and X-C. Jiang. 2003. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Arterioscler. Thromb. Vasc. Biol. 23: 1601-1607.
7. Yatsuya, H., K. Tamakoshi, H. Hattori, R. Otsuka, K. Wada, H. Zhang, T. Mabuchi, M. Ishikawa, C. Murata, T. Yoshida, et al. 2004. Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases. Circ. J. 68: 11-16.
8. Valenta, D. T., N. Ogier, G. Bradshaw, A. S. Black, D. J. Bonnet, L. Lagrost, L. K. Curtiss, and C. M. Desrumaux. 2006. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression. Arterioscler. Thromb. Vasc. Biol. 26: 1572-1578.
9. Vikstedt, R., D. Ye, J. Metso, R. B. Hildebrand, T. J. C. Van Berckel, C. Ehnholm, M. Jauhiainen, and M. Van Eck. 2007. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Arterioscler. Thromb. Vasc. Biol. 27: 578-586.
10. Stein, O., and Y. Stein. 1999. Atheroprotective mechanisms of HDL. Atherosclerosis. 144: 285-301.
11. Franceschini, G. 2001. Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease. Am. J. Cardiol. 88: 9N-13N.
12. Jiang, X-C., A. L. Tall, S. Qin, M. Lin, M. Schneider, F. Lalanne, V. Deckert, C. Desrumaux, A. Athias, J. L. Witztum, et al. 2002. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to enhanced accumulation of vitamin E. J. Biol. Chem. 277: 31850-31856.
13. 1-HDL. Biochim. Biophys. Acta. 1301: 255-262.
14. Lie, J., R. de Crom, M. Jauhiainen, T. van Gent, R. van Haperen, L. Scheek, H. Jansen, C. Ehnholm, and A. van Tol. 2001. Evaluation of phospholipid transfer protein and cholesterol ester transfer protein as contributors to the generation of preβ-high-density lipoproteins. Biochem. J. 360: 379-385.
15. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
16. Castro, G. R., and C. J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry. 27: 25-29.
17. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomquist, A. van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
18. Tu, A-Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
19. Jiang, X-C., O. L. Francone, C. Bruce, R. Milne, J. Mar, A. Walsh, J. L. Breslow, and A. R. Tall. 1996. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J. Clin. Invest. 98: 2373-2380.
20. Van Haperen, R., A. van Tol, P. Vermeulen, M. Jauhiainen, T. van Gent, P. van den Berg, S. Ehnholm, F. Grosveld, A. van der Kamp, and R. de Crom. 2000. Human plasma phospholipid transfer protein increases the anti-atherogenic potential of high density lipoproteins in transgenic mice. Arterioscler. Thromb. Vasc. Biol. 20: 1082-1088.
21. Curtiss, L. K., D. T. Valenta, N. J. Hime, and K-A. Rye. 2006. What is so special about apolipoprotein AI in reverse cholesterol transport? Arterioscler. Thromb. Vasc. Biol. 26: 12-19.
22. Boisvert, W. A., J. Spangenberg, and L. K. Curtiss. 1995. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96: 1118-1124.
23. Valenta, D. T., J. J. Bulgrien, C. L. Banka, and L. K. Curtiss. 2006. Overexpression of human apoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice. Atherosclerosis. 189: 255-263.
24. 14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim. Biophys. Acta. 712: 444-452.
25. Paigen, B., P. A. Morrow, D. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68: 231-240.
26. Tangirala, R. K., E. M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36: 2320-2328.
27. Laffitte, B. A., S. B. Joseph, M. Chen, A. Castrillo, J. Repa, D. Wilpitz, D. Mangelsdorf, and P. Tontonoz. 2003. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol. Cell. Biol. 23: 2182-2191.
28. Sammalkorpi, K., V. Valtonen, Y. Kerttula, E. Nikkilä, and M. R. Taskinen. 1988. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 37: 859-865.
29. Lewis, K. E., E. A. Kirk, T. O. McDonald, S. Wang, T. N. Wight, K. D. O'Brien, and A. Chait. 2004. Increase in serum amyloid A evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation. 110: 540-545.
30. Jiang, X-C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
31. Qin, S., K. Kawano, C. Bruce, M. Lin, C. Bisgaier, A. R. Tall, and X-C. Jiang. 2000. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J. Lipid Res. 41: 269-276.
32. Han, C. Y., T. Chiba, J. S. Campbell, N. Fausto, M. Chaisson, G. Orasanu, J. Plutzky, and A. Chait. 2006. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes. Arterioscler. Thromb. Vasc. Biol. 26: 1806-1813.
33. Cheung, M. C., B. G. Brown, E. K. Marino Larsen, A. D. Frutkin, K. D. O'Brien, and J. J. Albers. 2006. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochim. Biophys. Acta. 1762: 131-137.
34. Wolfbauer, G., J. J. Albers, and J. F. Oram. 1999. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim. Biophys. Acta. 1439: 65-76.
35. Oram, J. F., G. Wolfbauer, A. M. Vaughan, C. Tang, and J. J. Albers. 2003. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. J. Biol. Chem. 278: 52379-52385.
36. Yang, X., E. E. Schadt, S. Wang, H. Wang, A. P. Arnold, L. Ingram-Drake, T. A. Drake, and A. J. Lusis. 2006. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 16: 995-1004.